Market Access/ News/ News/ News/ Oncology Roche seeks Kadcyla boost to fend off Herceptin biosimilars George Underwood breast cancer, herceptin, Kadclya, Roche 0 Comment As biosimilar competition to Herceptin ramps up, Roche is looking to bolster its position in HER2-positive breast cancer Share X Roche seeks Kadcyla boost to fend off Herceptin biosimilars https://pharmaphorum.com/news/roche-seeks-new-kadcyla-indication/
